已收盘 07-02 16:00:00 美东时间
+0.050
+1.24%
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42
JP Morgan analyst Rodolfo Angele maintains Gerdau (NYSE:GGB) with a Overweight and raises the price target from $5.5 to $6.
06-25 22:30
Shares of industrial metals-related companies are trading higher after Presiden...
06-03 00:55
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24
UBS analyst Caio Greiner maintains Gerdau (NYSE:GGB) with a Buy and raises the price target from $4.6 to $5.25.
04-30 03:15
Gerdau (NYSE:GGB) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.15 by 33.33 percent. This is a 66.67 percent increase over earnings of $0.06 per share from the same
04-28 06:03
Companies Reporting Before The Bell • Alliance Res Partners (NASDAQ:ARLP) is es...
04-27 19:11
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
UBS analyst Caio Greiner maintains Gerdau (NYSE:GGB) with a Buy and raises the price target from $4.4 to $4.6.
04-03 02:43